Dr Mulholland is a medical oncologist who exclusively treats brain cancer - he is a current consultant at University College Hospital and is the chair of the HCA cancer care brain and CNS tumour board. He is also an honorary senior lecturer at UCL and a training programme director. 

His doctoral research was in genomic profiling in brain cancer at Cancer Research UK - this has led to his focus on developing biomarkers and targets for therapy in brain cancer, including the clinical trial portfolio of novel agents in brain cancer which he now runs at UCLH and nationally. 

He is a clinical lead in a European Consortium called Datrix, a multidisciplinary European collaboration to advance next-generation targeted hyperthermic cancer treatment for glioblastoma.

• Cancer prevention and screening 
• chemotherapy 
• bone marrow transplant